The Time for Public Pharma is Now
To make medicines more affordable, policymakers are increasingly turning to price controls and out-of-pocket caps. These measures, while lowering costs, leave decisions about which drugs to manufacture and distribute in private hands. If patients are to have reliable access to the medicines they need, the government must take on a more direct role in development, production, and provision.
Continue Reading